CDT Equity Inc. cotiza a 0.66 USD y tiene una capitalización bursátil de $26757. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor…
| Periodo | 2025-11 |
|---|---|
| Real | — |
| Estimado | — |
| Sorpresa | — |
| Métrica | CDT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -694.2% | -32.0% | -662.2% |
| Current Ratio | 0.34 | 2.84 | -2.50 |
| Debt / Equity | — | 0.28 | — |